These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17277625)

  • 1. Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma.
    Ertuğrul EE; Cincik H; Dogru S; Cekin E; Berber U; Gungor A; Poyrazoğlu IE
    Laryngoscope; 2007 Feb; 117(2):299-302. PubMed ID: 17277625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats.
    Ertuğrul EE; Cekin IE; Cincik H; Doğru S; Güngör A
    Otolaryngol Head Neck Surg; 2009 May; 140(5):720-3. PubMed ID: 19393418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model.
    Yoon YH; Rha KS; Koo BS; Park JY; Kim YM; Park YH
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):94-9. PubMed ID: 18585568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury.
    Ozçelik MF; Pekmezci S; Saribeyoğlu K; Unal E; Gümüştaş K; Doğusoy G
    Am J Surg; 2004 Feb; 187(2):257-60. PubMed ID: 14769315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutical effects of topical halofuginone hydrobromide in keloid management.
    Lista S; Emanuele E
    Med Hypotheses; 2007; 69(3):707. PubMed ID: 17331662
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
    Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
    Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis.
    Karatas A; Paksoy M; Erzin Y; Carkman S; Gonenc M; Ayan F; Aydogan F; Uzun H; Durak H
    J Surg Res; 2008 Jul; 148(1):7-12. PubMed ID: 18570924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
    Nagler A; Gofrit O; Ohana M; Pode D; Genina O; Pines M
    J Urol; 2000 Nov; 164(5):1776-80. PubMed ID: 11025768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofuginone prevents subglottic stenosis in a canine model.
    Eliashar R; Ochana M; Maly B; Pines M; Sichel JY; Nagler A
    Ann Otol Rhinol Laryngol; 2006 May; 115(5):382-6. PubMed ID: 16739671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study).
    Cincik H; Gungor A; Cakmak A; Omeroglu A; Poyrazoglu E; Yildirim S; Cekin E; Candan H
    Am J Otolaryngol; 2005; 26(1):45-50. PubMed ID: 15635581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
    Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
    Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis.
    Karakoyun B; Yüksel M; Ercan F; Salva E; Işik I; Yeğen BC
    Dig Dis Sci; 2010 Mar; 55(3):607-16. PubMed ID: 19390970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halofuginone inhibits collagen deposition in fibrous capsules around implants.
    Olbrich KC; Meade R; Bruno W; Heller L; Klitzman B; Levin LS
    Ann Plast Surg; 2005 Mar; 54(3):293-6;discussion 296. PubMed ID: 15725837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
    Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
    Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any synergic effect for coadministration of mitomycin C and halofuginone on the skin wound healing?
    Yoon YH; Rha KS; Kim DH; Kim EH; Kim JM; Koo BS
    Am J Otolaryngol; 2011; 32(2):130-4. PubMed ID: 20392524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits.
    Jaidane M; Ali-El-Dein B; Ounaies A; Hafez AT; Mohsen T; Bazeed M
    J Urol; 2003 Nov; 170(5):2049-52. PubMed ID: 14532851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis.
    Zeplin PH; Larena-Avellaneda A; Schmidt K
    Plast Reconstr Surg; 2010 Jul; 126(1):266-274. PubMed ID: 20595874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of burn scar formation by halofuginone-eluting silicone gel sheets: a controlled study on nude mice.
    Zeplin PH
    Ann Plast Surg; 2012 Mar; 68(3):271-5. PubMed ID: 22356780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraurethral Mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture.
    Ayyildiz A; Nuhoglu B; Gülerkaya B; Caydere M; Ustün H; Germiyanoglu C; Erol D
    Int J Urol; 2004 Dec; 11(12):1122-6. PubMed ID: 15663686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.
    Halevy O; Genin O; Barzilai-Tutsch H; Pima Y; Levi O; Moshe I; Pines M
    Histol Histopathol; 2013 Feb; 28(2):211-26. PubMed ID: 23275304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.